🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-517310-15-00
Authorised Phase I

A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease

2024-517310-15-00 · tracked via the Priya Life Science EU tracker
Sponsor
Mission Therapeutics Limited
Sponsor type
Pharmaceutical company
Therapeutic area
Nervous System Diseases
Decision date
18/05/2026
Enrollment target
18
Sites
Germany, Netherlands, France

Condition studied

Parkinson's Disease

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-517310-15-00 on CTIS ↗ ← All trials in the EU